Literature DB >> 17239455

Participation of transmembrane proline 82 in angiotensin II AT1 receptor signal transduction.

Rosana I Reis1, Edson L Santos, João B Pesquero, Laerte Oliveira, Joost P Schanstra, Jean-Loup Bascands, Christiane Pecher, Antonio C M Paiva, Claudio M Costa-Neto.   

Abstract

Most of the classical physiological effects of the octapeptide angiotensin II (AngII) are produced by activating the AT1 receptor which belongs to the G-protein coupled receptor family (GPCR). Peptidic GPCRs may be functionally divided in three regions: (i) extracellular domains involved in ligand binding; (ii) intracellular domains implicated in agonist-induced coupling to G protein and (iii) seven transmembrane domains (TM) involved in signal transduction. The TM regions of such receptors have peculiar characteristics such as the presence of proline residues. In this project we aimed to investigate the participation of two highly conserved proline residues (Pro82 and Pro162), located in TM II and TM IV, respectively, in AT1 receptor signal transduction. Both mutations did not cause major alterations in AngII affinity. Functional assays indicated that the P162A mutant did not influence the signal transduction. On the other hand, a potent deleterious effect of P82A mutation on signal transduction was observed. We believe that the Pro82 residue is crucial to signal transduction, although it is not possible to say yet if this is due to a direct participation or if due to a structural rearrangement of TM II. In this last hypothesis, the removal of proline residue might be correlated to a removal of a kink, which in turn can be involved in the correct positioning of residues involved in signal transduction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17239455     DOI: 10.1016/j.regpep.2006.11.028

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  6 in total

1.  An indel in transmembrane helix 2 helps to trace the molecular evolution of class A G-protein-coupled receptors.

Authors:  Julie Devillé; Julien Rey; Marie Chabbert
Journal:  J Mol Evol       Date:  2009-04-09       Impact factor: 2.395

Review 2.  Pharmacological modulation of chemokine receptor function.

Authors:  D J Scholten; M Canals; D Maussang; L Roumen; M J Smit; M Wijtmans; C de Graaf; H F Vischer; R Leurs
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Unique interaction pattern for a functionally biased ghrelin receptor agonist.

Authors:  Bjørn Sivertsen; Manja Lang; Thomas M Frimurer; Nicholas D Holliday; Anders Bach; Sylvia Els; Maja S Engelstoft; Pia S Petersen; Andreas N Madsen; Thue W Schwartz; Annette G Beck-Sickinger; Birgitte Holst
Journal:  J Biol Chem       Date:  2011-03-14       Impact factor: 5.157

4.  Molecular Determinants of the Intrinsic Efficacy of the Antipsychotic Aripiprazole.

Authors:  Carmen Klein Herenbrink; Ravi Verma; Herman D Lim; Anitha Kopinathan; Alastair Keen; Jeremy Shonberg; Christopher J Draper-Joyce; Peter J Scammells; Arthur Christopoulos; Jonathan A Javitch; Ben Capuano; Lei Shi; J Robert Lane
Journal:  ACS Chem Biol       Date:  2019-08-05       Impact factor: 5.100

5.  Pharmacological Characterization of 5-Substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: Novel Antagonists for the Histamine H3 and H4 Receptors with Anti-inflammatory Potential.

Authors:  Michelle F Corrêa; Álefe J R Barbosa; Larissa B Teixeira; Diego A Duarte; Sarah C Simões; Lucas T Parreiras-E-Silva; Aleksandro M Balbino; Richardt G Landgraf; Michel Bouvier; Claudio M Costa-Neto; João P S Fernandes
Journal:  Front Pharmacol       Date:  2017-11-14       Impact factor: 5.810

6.  Effect of Shenxinning decoction on ventricular remodeling in AT1 receptor-knockout mice with chronic renal insufficiency.

Authors:  Xuejun Yang; Hua Zhou; Huiyan Qu; Weifang Liu; Xiaojin Huang; Yating Shun; Liqun He
Journal:  Indian J Pharmacol       Date:  2014 Jul-Aug       Impact factor: 1.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.